19 related articles for article (PubMed ID: 7865908)
1. SUMOylation of RIG-I positively regulates the type I interferon signaling.
Mi Z; Fu J; Xiong Y; Tang H
Protein Cell; 2010 Mar; 1(3):275-83. PubMed ID: 21203974
[TBL] [Abstract][Full Text] [Related]
2. Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products.
Juhasz A; Frankel P; Cheng C; Rivera H; Vishwanath R; Chiu A; Margolin K; Yen Y; Newman EM; Synold T; Wilczynski S; Lenz HJ; Gandara D; Albain KS; Longmate J; Doroshow JH
J Clin Lab Anal; 2003; 17(5):184-94. PubMed ID: 12938148
[TBL] [Abstract][Full Text] [Related]
3. Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines.
Leclerc GJ; Leclerc GM; Barredo JC
Cancer Cell Int; 2002 Mar; 2(1):1. PubMed ID: 11988110
[TBL] [Abstract][Full Text] [Related]
4. Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues.
Leclerc GJ; Barredo JC
Clin Cancer Res; 2001 Apr; 7(4):942-51. PubMed ID: 11309345
[TBL] [Abstract][Full Text] [Related]
5. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
6. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
Johnson TB; Nair MG; Galivan J
Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560
[TBL] [Abstract][Full Text] [Related]
7. Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development.
Barredo J; Moran RG
Mol Pharmacol; 1992 Oct; 42(4):687-94. PubMed ID: 1435744
[TBL] [Abstract][Full Text] [Related]
8. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients.
Lenz HJ; Danenberg K; Schnieders B; Goeker E; Peters GJ; Garrow T; Shane B; Bertino JR; Danenberg PV
Oncol Res; 1994; 6(7):329-35. PubMed ID: 7865908
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the chemistry and biology of folypoly-gamma-glutamate synthetase substrates and inhibitors.
Gangjee A; Dubash NP; Zeng Y; McGuire JJ
Curr Med Chem Anticancer Agents; 2002 May; 2(3):331-55. PubMed ID: 12678736
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
